Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
According to DataHorizzon Research, the Active Pharmaceutical Ingredients (API) Market size was valued at USD 151.2 Billion in 2022 and is expected to reach USD 346.4 Billion by 2032 at a CAGR of 8.7%.
read more
Thursday, October 19, 2023
As of November 1st, 2023, Dr. Stephan Haitz will assume the role of President of the Novasep CDMO Business Unit and will become a member of the company's Executive Committee, succeeding Jean Bléhaut, who is departing the company after a distinguished...
read more
Willow Biosciences Inc., (“Willow”) and SUANFARMA today jointly announced execution of a collaboration agreement for a cell line productivity optimization development program for
manufacturing a large volume anti-infective Active Pharmaceutical ...
read more
Croda broke ground on 9 May 2023 on its newest manufacturing facility in Lamar, Clinton County, Pennsylvania.
read more
ASM Research Chemicals, a contract research and development services provider specialized in organic chemistry, is launching its new development pack (referred to as DevPack) service intended for active pharmaceutical ingredients (APIs) manufacturing...
read more
Framework Solutions announced the appointment of Russ Belden as Head of Commercial Solutions, effective April 26th, 2023.
read more
Wheeler Bio, Inc., a boutique contract development and manufacturing organization (CDMO) specializing in process development and small batch CGMP production of therapeutic antibodies, announced the closing of their Series A financing round.
read more
WuXi STA, a global Contract Research, Development, and Manufacturing Organization (CRDMO) has added two 2,000 L reactors and a large-scale continuous purification system for peptide manufacturing at its Changzhou campus.
read more
Thursday, February 23, 2023
AllCells®, a Discovery Life Sciences™ company announced the expansion of its apheresis network with the addition of two new centers in Houston, Texas, and Huntsville, Alabama. These new centers complement AllCells' existing presence in two major U.S....
read more
Thursday, January 12, 2023
CordenPharma is pleased to announce the signing of a multi-year agreement commencing in 2023 for the contract manufacturing of a large-volume peptide at its CordenPharma Colorado facility.
read more
Tuesday, January 10, 2023
Sterling Pharma Solutions announced the completion of its acquisition of an active pharmaceutical ingredient (API) manufacturing facility in Ringaskiddy, Ireland, from Novartis, in a deal that was initially announced in March 2022.
read more
Agilent Technologies Inc. announced it is investing approximately $725 million to double manufacturing capacity of therapeutic nucleic acids in response to rapid growth of the $1 billion market and strong demand for the company’s high-quality active ...
read more
Monday, December 05, 2022
Lonza announced the start of new mid-scale manufacturing assets at its API manufacturing center in Nansha, China.
read more
Monday, November 21, 2022
Cambrex entered an agreement to acquire Snapdragon Chemistry, a leading US-based provider of chemical process development services to a broad range of emerging and established biopharma customers.
read more
Thursday, November 17, 2022
GE Healthcare’s Pharmaceutical Diagnostics business announced an $80 million investment to increase manufacturing capacity by 30 percent at its Active Pharmaceutical Ingredients (API) site in Lindesnes, Norway.
read more